FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943778644> ?p ?o ?g. }

• W2943778644 endingPage "55" @default.
• W2943778644 startingPage "55" @default.
• W2943778644 abstract "Microbial resistance to currently available antibiotics is a public health problem in the fight against infectious diseases. Most antibiotics are characterized by numerous side effects that may be harmful to normal body cells. To improve the efficacy of these antibiotics and to find an alternative way to minimize the adverse effects associated with most conventional antibiotics, piperine and piperlongumine were screened in combination with conventional rifampicin, tetracycline, and itraconazole to evaluate their synergistic, additive, or antagonistic interactions against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. The fractional inhibitory concentration index was used to estimate the synergistic effects of various combination ratios of the piperamides and antibiotics against the bacterial and fungal strains. Both piperine and piperlongumine showed synergistic effects against S. aureus when combined at various ratios with rifampicin. Synergistic interaction was also observed with piperine in combination with tetracycline against S. aureus, while antagonistic interaction was recorded for piperlongumine and tetracycline against S. aureus. All the piperamide/antibacterial combinations tested against P. aeruginosa showed antagonistic effects, with the exception of piperine and rifampicin, which recorded synergistic interaction at a ratio of 9:1 rifampicin/piperine. No synergistic interaction was observed when the commercial compounds were combined with itraconazole and tested against C. albicans. The results showed that piperine and piperlongumine are capable of improving the effectiveness of rifampicin and tetracycline. Dosage combinations of these bioactive compounds with the antibiotics used may be a better option for the treatment of bacterial infections that aims to minimize the adverse effects associated with the use of these conventional antibacterial drugs." @default.
• W2943778644 created "2019-05-09" @default.
• W2943778644 creator A5020521686 @default.
• W2943778644 creator A5025095878 @default.
• W2943778644 creator A5031195190 @default.
• W2943778644 creator A5049994582 @default.
• W2943778644 date "2019-05-04" @default.
• W2943778644 modified "2023-10-13" @default.
• W2943778644 title "Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials" @default.
• W2943778644 cites W1994773286 @default.
• W2943778644 cites W2003565285 @default.
• W2943778644 cites W2027017549 @default.
• W2943778644 cites W2031348290 @default.
• W2943778644 cites W2041298435 @default.
• W2943778644 cites W2052873409 @default.
• W2943778644 cites W2053664273 @default.
• W2943778644 cites W2061617691 @default.
• W2943778644 cites W2065282851 @default.
• W2943778644 cites W2067018229 @default.
• W2943778644 cites W2071053154 @default.
• W2943778644 cites W2075287054 @default.
• W2943778644 cites W2100011933 @default.
• W2943778644 cites W2103220533 @default.
• W2943778644 cites W2107427748 @default.
• W2943778644 cites W2107794472 @default.
• W2943778644 cites W2111264921 @default.
• W2943778644 cites W2129819819 @default.
• W2943778644 cites W2138142499 @default.
• W2943778644 cites W2138686831 @default.
• W2943778644 cites W2159355055 @default.
• W2943778644 cites W2170764510 @default.
• W2943778644 cites W2171155970 @default.
• W2943778644 cites W2180925826 @default.
• W2943778644 cites W2224929295 @default.
• W2943778644 cites W2326823588 @default.
• W2943778644 cites W2402894493 @default.
• W2943778644 cites W2412137692 @default.
• W2943778644 cites W2620381907 @default.
• W2943778644 cites W2625373273 @default.
• W2943778644 cites W2729462016 @default.
• W2943778644 cites W2767461967 @default.
• W2943778644 cites W2793436367 @default.
• W2943778644 cites W2810547043 @default.
• W2943778644 cites W2884803022 @default.
• W2943778644 cites W2949599311 @default.
• W2943778644 doi "https://doi.org/10.3390/antibiotics8020055" @default.
• W2943778644 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6627571" @default.
• W2943778644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31060239" @default.
• W2943778644 hasPublicationYear "2019" @default.
• W2943778644 type Work @default.
• W2943778644 sameAs 2943778644 @default.
• W2943778644 citedByCount "35" @default.
• W2943778644 countsByYear W29437786442019 @default.
• W2943778644 countsByYear W29437786442020 @default.
• W2943778644 countsByYear W29437786442021 @default.
• W2943778644 countsByYear W29437786442022 @default.
• W2943778644 countsByYear W29437786442023 @default.
• W2943778644 crossrefType "journal-article" @default.
• W2943778644 hasAuthorship W2943778644A5020521686 @default.
• W2943778644 hasAuthorship W2943778644A5025095878 @default.
• W2943778644 hasAuthorship W2943778644A5031195190 @default.
• W2943778644 hasAuthorship W2943778644A5049994582 @default.
• W2943778644 hasBestOaLocation W29437786441 @default.
• W2943778644 hasConcept C185592680 @default.
• W2943778644 hasConcept C2778607973 @default.
• W2943778644 hasConcept C2779489039 @default.
• W2943778644 hasConcept C2780133158 @default.
• W2943778644 hasConcept C2780917455 @default.
• W2943778644 hasConcept C2780923616 @default.
• W2943778644 hasConcept C4937899 @default.
• W2943778644 hasConcept C501593827 @default.
• W2943778644 hasConcept C523546767 @default.
• W2943778644 hasConcept C54355233 @default.
• W2943778644 hasConcept C71924100 @default.
• W2943778644 hasConcept C86803240 @default.
• W2943778644 hasConcept C89423630 @default.
• W2943778644 hasConcept C98274493 @default.
• W2943778644 hasConceptScore W2943778644C185592680 @default.
• W2943778644 hasConceptScore W2943778644C2778607973 @default.
• W2943778644 hasConceptScore W2943778644C2779489039 @default.
• W2943778644 hasConceptScore W2943778644C2780133158 @default.
• W2943778644 hasConceptScore W2943778644C2780917455 @default.
• W2943778644 hasConceptScore W2943778644C2780923616 @default.
• W2943778644 hasConceptScore W2943778644C4937899 @default.
• W2943778644 hasConceptScore W2943778644C501593827 @default.
• W2943778644 hasConceptScore W2943778644C523546767 @default.
• W2943778644 hasConceptScore W2943778644C54355233 @default.
• W2943778644 hasConceptScore W2943778644C71924100 @default.
• W2943778644 hasConceptScore W2943778644C86803240 @default.
• W2943778644 hasConceptScore W2943778644C89423630 @default.
• W2943778644 hasConceptScore W2943778644C98274493 @default.
• W2943778644 hasIssue "2" @default.
• W2943778644 hasLocation W29437786441 @default.
• W2943778644 hasLocation W29437786442 @default.
• W2943778644 hasLocation W29437786443 @default.
• W2943778644 hasLocation W29437786444 @default.
• W2943778644 hasLocation W29437786445 @default.
• W2943778644 hasLocation W29437786446 @default.

• next